Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11773103 IRAK4 degraders and uses thereof

Patent 11773103 was granted and assigned to Kymera Therapeutics on October, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Kymera Therapeutics

Current Assignee

Kymera Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11773103

Patent Inventor Names

Haojing Rong

Brad Enerson

Date of Patent

October 3, 2023

Patent Application Number

17651202

Date Filed

February 15, 2022

Patent Citations

‌

US Patent 8906682 Methods for treatment of cancer

‌

US Patent 7390799 Apoptosis promoters

‌

US Patent 7501496 Anti-OX40L antibodies

‌

US Patent 8138347 Quinoline derivatives as PI3 kinase inhibitors

‌

US Patent 11352350 IRAK degraders and uses thereof

Patent Citations Received

‌

US Patent 12091411 IRAK degraders and uses thereof

Patent Primary Examiner

CPC Code

Patent abstract

The present invention relates to a method of treating autoimmune/autoinflammatory diseases and hematological malignancies in a subject.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11773103 IRAK4 degraders and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API